Health Equity studies
Assessing Treatment Patterns and Quality Gaps in Non-Muscle Invasive Bladder Cancer Care
The goal of this study was to understand reasons for the use/non-use of intravesical chemotherapy or immunotherapy following the initial bladder tumor resection among patients with bladder cancer.
Principal Investigator:Kim N. Danforth, ScD, MPH
Funding Source:Kaiser Permanente, Southern California
Funding Years:2013 - 2014
Effectiveness of Gastric Sleeve vs. Gastric Bypass for Cardiovascular Disease (ENGAGE-CVD)
This study will include only bariatric surgery patients from Kaiser Permanente Southern California and is designed to achieve the following aims: 1) compare the effectiveness of vertical sleeve gastrectomy (VSG) and Roux-en-Y Gastric Bypass (RYGB) in remission of risk factors for cardiovascular disease (CVD) and reduction in overall CVD risk using advanced statistical and econometric techniques.; 2) compare VSG and RYGB surgical safety using similar methods; and 3) understand the treatment effect heterogeneity in remission of CVD risk factors, reduction in overall CVD risk, and safety outcomes for patients with different racial/ethnic backgrounds, sexes, and disease burdens at the time of surgery.